e-learning
resources
Berlin 2008
Monday, 06.10.2008
Treatment and outcome in hospitalised patients with community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk factors of treatment failure of community acquired pneumonia in patients with COPD
U. Sohta, M. Kato, C. Yonemoto, Y. Koshimo, N. Tanabe, K. Miura, S. Goto, M. Kawashima (Kishiwada/Osaka, Japan)
Source:
Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Session:
Treatment and outcome in hospitalised patients with community-acquired pneumonia
Session type:
E-Communication Session
Number:
1853
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Sohta, M. Kato, C. Yonemoto, Y. Koshimo, N. Tanabe, K. Miura, S. Goto, M. Kawashima (Kishiwada/Osaka, Japan). Risk factors of treatment failure of community acquired pneumonia in patients with COPD. Eur Respir J 2008; 32: Suppl. 52, 1853
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Mortality in patients with COPD due to community acquired pneumonia
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
Risk factors contributing to mortality in patients with COPD developing acute respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007
Risk factors of mortality in COPD patients with ventilator associated pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 50s
Year: 2007
Risk factors for hospitalization of an acute exacerbation of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006
Risk factors for mortality in patients with COPD exacerbation
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Risk factors in elderly patients with acute respiratory failure
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012
Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Risk contribution of comorbidities in hospitalized patients with Covid 19 pneumonia
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Risk factors for immunosuppression in hospitalized patients coming from the community with pneumonia: a worldwide perspective
Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Year: 2018
Risk factors for bacterial infection in exacerbated COPD requiring admission
Source: Eur Respir J 2001; 18: Suppl. 33, 153s
Year: 2001
Treatment failure of community-acquired pneumonia: risk factors and consequences
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012
Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004
Risk factors of death in patients with COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
COPD is an independent risk factor for mortality in community acquired pneumonia
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
Factors affecting one year mortality of hospitalized patients with COPD exacerbation and respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 321s
Year: 2007
Risk factors for noninvasive ventilatory support failure in patients with COVID-19 pneumonia
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021
Risk factors associated with hospitalized asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 51s
Year: 2001
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept